Neurotron Raises $16.5 Million for Cochlear Implant Business
December 26, 2013 -- Neurotron Biotechnology, a Hangzhou medical device company, raised “as much as” 100 million RMB ($16.5 million) in a C funding round. Neurotron has developed a 24-channel cochlear implant that it sells for $16,000, which is half the cost of the market-leading import made by Australia’s Cochlear (ASX: COH). Investors in the C round were Kleiner Perkins Caulfield Byers and DT Capital Partners. Qiming was the sole investor in Neurotron’s previous two rounds. More details....
Help employers find you! Check out all the jobs and post your resume.
